透過您的圖書館登入
IP:18.216.190.167
  • 期刊

Thyroid Metastasis from Lung Adenocarcinoma: Report of a Case

肺腺癌轉移至甲狀腺:一病例報告

摘要


轉移至甲狀腺是非常罕見的,既使它具有豐富的血管。來自肺癌的甲狀腺轉移是惡劣的預後指數而它的平均存活的時間是二個月。我們提出一44歲女性因肺腺癌轉移至甲狀腺接受酪胺酸kinase抑制劑(TKI)標靶治療。最後病人對標靶治療無效而死亡。

關鍵字

肺癌 甲狀腺 腫瘤轉移

並列摘要


Metastasis to the thyroid gland is rare, despite the rich vascular supply. Thyroid metastasis from lung carcinoma indicates a poor prognosis, and the average survival is 2 months. We report a 44-year-old woman with adenocarcinoma of the lung metastatic to the thyroid that responded poorly to tyrosine kinase inhibitor (TKI) target therapy. Ultimately, the patient succumbed to her disease.

並列關鍵字

lung cancer thyroid gland metastases

延伸閱讀